There are limited studies regarding ACE inhibitors on QoL amongst cancer patients, but there is a phase two study on the ability of ACE inhibitor (captopril)to alter the incidence of pulmonary damage after radiation therapy and also quality of life in patients with lung cancer.(Small, James et al., 2018). The gene discussed is ACE; the disease is cancer.